I wouldn't give $10 for Symantec, never mind $10bn. Bloody shysters.
When the chips are down, buy a software biz: Broadcom snaffles Symantec for $10.7bn
Broadcom has swallowed Symantec for a bargain-bin price of $10.7bn (£8.82bn) in cash, boosting the chip maker's enterprise security clout. Word of Broadcom's intentions first surfaced in early July as the firm sought to broaden its software portfolio. The deal looked good to go for $15.5bn until negotiations faltered when …
COMMENTS
-
-
Friday 9th August 2019 14:37 GMT Anonymous Coward
My reading was that Symantec wanted more but due diligence showed that it was in fact worth less and so Broadcom walked away.
I think Symantec C-level staff did the right thing (acting as cheer leaders for their company regardless of whether it is a pile of crap...).
And Broadcom did the right thing by looking under the covers and realizing all is not well.
And for the CEO role in HP, I don't believe their recruitment procedures require C-level staff to be able to tell their rear ends from their elbows let alone cover more complex issues such as acquisitions. The only real requirement is to collect their bonus each time they pass go^H^H^Hanother year.
-
Sunday 11th August 2019 12:17 GMT ifekas
A couple of years ago at work after purchasing SOPHOS UTMs, we started migrating our endpoint protection from Symantec to SOPHOS, but in the end we decided to stop this; we currently use both but find the overhead with Symantec significantly lower, and if anything we find Symantec EP the better product. Hopefully it will continue to do the job well.
-
This post has been deleted by its author
-
Monday 12th August 2019 22:43 GMT ocflyfish
Unhappy Symantec user
We have a few hundred endpoints using SEP. I was becoming concerned when multiple vulnerabilities with SEP were discovered that put our systems at greater risk. The final straw for me was when I discovered two weeks ago that SEP had stopped functioning on more than 50% of our devices but didn't generate any warnings alerting us to the situation.
Taking a long hard look at Vipre when our licensing expires next year.